Dr. Reddy's Laboratories’ wholly owned subsidiary -- Dr. Reddy's Research and Development B. V. has entered into an asset purchase agreement for sale of its certain assets and liabilities including transfer of employees at site situated at Zernikedreef 12, 2333, CL Leiden, The Netherlands. Dr. Reddy's Research and Development B. V. has entered into an asset purchase agreement with Delpharm Development Leiden BV, part of France-based Delpharm Group.
The agreed consideration for the assets and liabilities of the said site is Euro 1. Further the company has agreed to pay to the purchaser a compensation of Euro 11.35 million for certain operating expenses related to the site. The compensation would be increased by an amount of Euro 1,50,000 upon satisfaction of certain conditions. Post this, no further payment would be made to the purchaser. It expects the deal to conclude by December 31, 2022.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: